Know your lesion
Optimize DCB treatment to enable durable AVF maintenance outcomes
Maintaining a functional arteriovenous fistula (AVF) is critical for effective hemodialysis1. Yet not all stenoses behave the same.
Understanding lesion morphology and biology can help physicians anticipate which lesions are most likely to benefit from drug-coated balloon (DCB) therapy and improve long-term access outcomes.
Explore expert insights on how lesion type influences treatment strategy and why recognizing these differences is key to optimizing DCB treatment.
When lesion type changes the equation for DCB
Watch leading experts explore how lesion morphology, biology, and clinical strategy shape optimal AVF maintenance, and where DCBs can deliver the greatest benefit.
Start with the lesion: imaging as the foundation of optimal AVF management
Before selecting a therapy, physicians must first understand the lesion they are treating. Dr Steiner explains how systematic AVF assessment can guide optimal treatment decisions.
When biology drives benefit: how lesion morphology shapes DCB response
Lesion morphology matters. Prof. Tozzi explains how understanding lesion characteristics can guide treatment decisions, and introduces a lesion-type classification reflecting the three stages of neointimal hyperplasia evolution.
From de novo to restenotic lesions
When DCB should be considered as first line treatment for optimal AVF maintenance? Watch this expert discussion outlining the scientific basis for DCB treatment across AVF lesion types.